Use of β-Adrenoceptor Blocking Drugs in Hyperthyroidism (original) (raw)

• Abadie, E.; Leclercq, J.F. and Passa, Ph.: Pindolol and hyperthyroidism. New England Journal of Medicine 309: 795 (1983).
  PubMed CAS Google Scholar
• Alavez, E. and Quirantes, A.: Propranolol (Inderal) therapy in pre-operative care for diffuse toxic goitre. Preliminary report. Revue Roumanian Medicine 12: 113–117 (1974).
  CAS Google Scholar
• Alderman, E.L.; Davies, R.O.; Crowley, J.J.; Lopes, M.G.; Brooker, J.L.; Friedman, J.P.; Graham, A.F.; Matlof, H.J. and Harrison, D.C.: Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation 51: 964–975 (1975).
  PubMed CAS Google Scholar
• Allen, J.A.; Lowe, D.C; Roddie, I.D. and Wallace, W.F.M.: Studies on sweating in clinical and experimental thyrotoxicosis. Clinical Science and Molecular Medicine 45: 765–773 (1973).
  PubMed CAS Google Scholar
• Amino, N.; Mori, H.; Iwatani, Y.; Tanizawa, O.; Kawashima, M.; Tsuge, I.; Ibaragi, K.; Kumahara, Y. and Miyai, K.: High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. New England Journal of Medicine 306: 849–852 (1982).
  PubMed CAS Google Scholar
• Anderberg, B.; Koagedal, B.; Nilsson, O.R.; Smeds, S.; Tegler, L. and Gillquist, J.: Propranolol and thyroid resection for hyperthyroidism. Acta Chirurgica Scandinavica 145: 297–303 (1979).
  PubMed CAS Google Scholar
• Aro, A.; Antilla, M.; Korhonen, T. and Sundquist, H.: Pharmacokinetics of propranolol and sotalol in hyperthyroidism. European Journal of Clinical Pharmacology 21: 373–378 (1982).
  PubMed CAS Google Scholar
• Aro, A.; Huttunen, J.K.; Lamberg, B.A.; Pelkonen, R.; Ikkala, E.; Kuusisto, A.; Rissanen, V.; Salmi, J. and Tervonen, S.: Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy for hyperthyroidism. Acta Endocrinologica 96: 321–327 (1981).
  PubMed CAS Google Scholar
• Barsotti, M.M.; Targovnik, J.H. and Verso, T.A.: Thyrotoxicosis, hypercalcaemia and secondary hyperparathyroidism. Archives of Internal Medicine 139: 661–663 (1979).
  PubMed CAS Google Scholar
• Bashir, A.Y.; Nasef, A.; Ibrahim, A.H.; Kenawi, M.M.; El-Malek, W.A. and Ageeb, M.: Ten years experience with the use of β-adrenergic blockers in the pre-operative preparation of thyrotoxic patients. Journal of the Egyptian Medical Association 61: 1–9 (1978).
  PubMed CAS Google Scholar
• Bax, N.D.S.; Lennard, M.S. and Tucker, G.T.: Effect of beta-blockers on thyroid hormone. British Medical Journal 281: 1283 (1980).
  PubMed CAS Google Scholar
• Bell, J.M.; Russell, C.J.; Nelson, J.K.; Kelly, J.C. and McDevitt, D.G.: Studies of the effect of thyroid dysfunction on the elimination of β-adrenoceptor blocking drugs. British Journal of Clinical Pharmacology 4: 79–82 (1977).
  PubMed CAS Google Scholar
• Bernard, C.: Leçons sur la physiologie de la pathologie du systeme nerveux, Vols 1 & 2 (J.B. Balliere et Fils, Paris 1858).
  Google Scholar
• Buckle, R.M.: Treatment of thyroid crisis by beta adrenergic blockade. Acta Endocrinologica 57: 168–176 (1968).
  PubMed CAS Google Scholar
• Canary, J.J.: Preparation of the thyrotoxic patient for surgery. Comprehensive Therapeutics 6(8): 26–32 (1980).
  CAS Google Scholar
• Cannon, W.B.; Binger, C.A.L. and Fitz, R.: Experimental hyperthyroidism. American Journal of Physiology 36: 363–364 (1915).
  Google Scholar
• Carruthers, S.G.; Ghosal, A.; McDevitt, D.G.; Nelson, J.K. and Shanks, R.G.: The assessment of β-adrenoceptor blocking drugs in hyperthyroidism. British Journal of Clinical Pharmacology 1: 93–98 (1974).
  PubMed CAS Google Scholar
• Caswell, H.T.; Marks, A.D. and Channick, B.J.: Propranolol for the preoperative preparation of patients with thyrotoxicosis. Surgery, Gynaecology and Obstetrics 146: 908–910 (1978).
  CAS Google Scholar
• Chapdelaine, A.; Coulombe, R. and Lelorier, J.: The effects of propranolol, practolol and placebo on the clinical manifestations of thyrotoxicosis. International Journal of Clinical Pharmacology 14: 303–312 (1976).
  Google Scholar
• Cohen, M.V.; Schulman, I.C.; Spenillo, A. and Surks, M.I.: Effects of thyroid hormone on left ventricular function in patients treated for thyrotoxicosis. American Journal of Cardiology 48: 33–38 (1981).
  PubMed CAS Google Scholar
• Conway, M.J.; Eaton, R.P. and Siebel, J.A.: Thyrotoxicosis and periodic paralysis; improvement with beta blockade. Annals of Internal Medicine 81: 332–336 (1974).
  PubMed CAS Google Scholar
• Creagh, F.; Lazarus, J.; Griffiths, E. and Kadury, S.: Thyroid and cardiac effects of timolol in the treatment of hyperthyroidism. Clinical Science 63: 10P–11P (1982).
  Google Scholar
• Critchley, M. and Gulliford, P.: An equilibrium radionuclide technique to assess the effect of propranolol on left ventricular function in thyrotoxicosis. Clinical Radiology 31: 717–722 (1980).
  PubMed CAS Google Scholar
• Culhed, I. and Parrow, A.: Acute hemodynamic changes following beta-adrenergic blockade in hyperthyroidism. Acta Medica Scandinavica 184: 235–239 (1968).
  Google Scholar
• Das, G. and Krieger, M.: Treatment of thyrotoxic storm with intravenous administration of propranolol. Annals of Internal Medicine 70: 985–988 (1969).
  PubMed CAS Google Scholar
• Dial, P. and Hastings, P.R.: The use of selective beta-adrenergic receptor blockers for the preoperative preparation of thyrotoxic patients. Annals of Surgery 196: 633–635 (1982).
  PubMed CAS Google Scholar
• Dobyns, B.M.: Prevention and management of hyperthyroid storm. World Journal of Surgery 2: 293–306 (1978).
  PubMed CAS Google Scholar
• Eriksson, M.; Rubenfeld, S.; Garber, A.J. and Kohler, P.O.: Propranolol does not prevent thyroid storm. New England Journal of Medicine 296: 263–264 (1977).
  PubMed CAS Google Scholar
• Feek, C.M.; Sawers, J.S.A.; Irvine, W.J.; Beckett, G.J.; Ratcliffe, W.A. and Toft, A.D.: Combination of potassium iodide and propranolol in preparation of patients with Graves’ disease for thyroid surgery. New England Journal of Medicine 302: 883–885 (1980).
  PubMed CAS Google Scholar
• Feely, J.: Potassium shift in thyrotoxic periodic paralysis. Postgraduate Medical Journal 57: 238–239 (1981a).
  PubMed CAS Google Scholar
• Feely, J.: Propranolol and the hypercalcaemia of thyrotoxicosis. Acta Endocrinologica 98: 528–532 (1981b).
  PubMed CAS Google Scholar
• Feely, J.: Clinical pharmacokinetics of β-adrenoceptor blocking drugs in thyroid disease. Clinical Pharmacokinetics 8: 1–16 (1983).
  PubMed CAS Google Scholar
• Feely, J.; Crooks, J.; Forrest, A.L.; Hamilton, W.F. and Gunn, A.: Propranolol in the surgical treatment of hyperthyroidism, including severely thyrotoxic patients. British Journal of Surgery 68: 865–869 (1981a).
  PubMed CAS Google Scholar
• Feely, J.; Crooks, J.; Forrest, A.L.; Hamilton, W.F.; Gunn, A. and Browning, M.C.K.: Altered endocrine response to partial thyroidectomy in propranolol-prepared patients. Clinical Endocrinology 14: 597–604 (1981b).
  PubMed CAS Google Scholar
• Feely, J.; Crooks, J. and Stevenson, I.H.: The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration. British Journal of Clinical Pharmacology 12: 73–78 (1981d).
  PubMed CAS Google Scholar
• Feely, J.; Forrest, A.L.; Gunn, A.; Hamilton, W.F.D.; Stevenson, I.H. and Crooks, J.: Beta-blocking drugs and thyroid function. British Medical Journal 4: 1352 (1977).
  Google Scholar
• Feely, J.; Forrest, A.; Gunn, A.; Hamilton, W.; Stevenson, I. and Crooks, J.: Propranolol dosage in thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 51: 658–661 (1980b).
  PubMed CAS Google Scholar
• Feely, J.; Forrest, A.; Gunn, A.; Hamilton, W.; Stevenson, I. and Crooks, J.: Influence of surgery on plasma propranolol levels and protein binding. Clinical Pharmacology and Therapeutics 28: 759–764 (1980c).
  PubMed CAS Google Scholar
• Feely, J.; Isles, T.E.; Ratcliffe, W.A. and Crooks, J.: Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease. Clinical Endocrinology 10: 531–538 (1979).
  PubMed CAS Google Scholar
• Feely, J.; Stevenson, I.H. and Crooks, J.: Propranolol dynamics in thyrotoxicosis. Clinical Pharmacology and Therapeutics 28: 40–44 (1980a).
  PubMed CAS Google Scholar
• Feely, J.; Stevenson, I.H. and Crooks, J.: Increased clearance of propranolol in thyrotoxicosis. Annals of Internal Medicine 94: 472–474 (1981c).
  PubMed CAS Google Scholar
• Forfar, J.C.; Muir, A.L. and Toft, A.D.: Influence of thyroid hormones on left ventricular function evidence for impairment of myocardial contractility in both hyper- and hypothyroidism. Annales d’Endocrinologie 43: 42A (1982b).
  Google Scholar
• Forfar, J.C.; Sawers, S.A. and Toft, A.D.: Cardiovascular responses in hyperthyroidism before and during β-adrenoceptor blockade: Evidence against adrenergic hypersensitivity. Clinical Endocrinology 16: 441–452 (1982a).
  PubMed CAS Google Scholar
• Galaburda, M.; Rossman, N.P. and Haddow, J.E.: Thyroid storm in an 11 year old boy managed by propranolol. Pediatrics 53: 920–922 (1974).
  PubMed CAS Google Scholar
• Gardner, L.I.: Is propranolol alone really beneficial in neonatal thyrotoxicosis? Bradycardia and hypoglycaemia evoke the doctrine of primum non noctere. American Journal of Diseases in Children 134: 819–820 (1980).
  CAS Google Scholar
• Georges, L.P.; Santangelo, R.P.; Mackin, J.F. and Canary, J.J.: Metabolic effects of propranolol in thyrotoxicosis. Metabolism 24: 11–21 (1975).
  PubMed CAS Google Scholar
• Georges, L.P. and Sode, J.: Thyrotoxic hypercalcaemia treated with propranolol. New England Journal of Medicine 294: 1123–1124 (1976).
  Google Scholar
• Gibberd M.G. and Staffurth, J.S.: Oxprenolol in thyrotoxicosis. Lancet 1: 205 (1973).
  PubMed CAS Google Scholar
• Granville-Grossman, K.L. and Turner, P.: The effect of propranolol on anxiety. Lancet 1: 788–790 (1966).
  PubMed CAS Google Scholar
• Grossman, W.; Robin, N.I.; Johnson, L.W.; Brooks, H.L.; Selenkow, H.A. and Dexter, L.: The enhanced myocardial contractility of thyrotoxicosis. Role of the beta adrenergic receptor. Annals of Internal Medicine 74: 869–874 (1971a).
  PubMed CAS Google Scholar
• Grossman, W.; Robin, N.I.; Johnson, L.W.; Brooks, H.; Selenkow, H.A. and Dexter, L.: Effects of beta blockade on the peripheral manifestations of thyrotoxicosis. Annals of Internal Medicine 74: 875–879 (1971b).
  PubMed CAS Google Scholar
• Habib, A. and McCarthy, J.S.: Effects on the neonate of propranolol administration during pregnancy. Journal of Pediatrics 91: 808–811 (1977).
  PubMed CAS Google Scholar
• Hadden, D.R.; Montgomery, D.A.D.; Shanks, R.G. and Weaver, J.A.: Propranolol and iodine-131 in the management of thyrotoxicosis. Lancet 2: 852–854 (1968).
  PubMed CAS Google Scholar
• Hallengren, B.; Nilsson, O.R.; Karlberg, B.E.; Melander, A.; Tegler, L. and Wåhlin-Boll, E.: Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol. European Journal of Clinical Pharmacology 21: 379–384 (1982).
  PubMed CAS Google Scholar
• Harrower, A.D.; Fyffe, J.A.; Horn, D.B. and Strong, J.A.: Thyroxine and triidothyronine levels in hyperthyroid patients during treatment with propranolol. Clinical Endocrinology 7: 41–44 (1977).
  PubMed CAS Google Scholar
• Heyma, P.; Larkins, R.G.; Higginbotham, L. and Wah, NgK.: D-propranolol and DL-propranolol both decrease conversion of 1-thyroxine to 1-triiodothyronine. British Medical Journal 281: 24–25 (1980).
  PubMed CAS Google Scholar
• Hollifield, J.W.; Sherman, K.; Van der Zwagg, R. and Shand, D.G.: Proposed mechanism of propranolol’s antihypertensive effect in essential hypertension. New England Journal of Medicine 295: 68–73 (1976).
  PubMed CAS Google Scholar
• How, J.; Khir, A.S.M. and Bewsher, P.D.: The effect of atenolol on serum thyroid hormones in hyperthyroid patients. Clinical Endocrinology 13: 299–302 (1980).
  PubMed CAS Google Scholar
• Howitt, G. and Rowlands, D.J.: Beta-sympathetic blockade in hyperthyroidism. Lancet 1: 628–631 (1966).
  PubMed CAS Google Scholar
• Howitt, G.; Rowlands, D.J.; Leung, D.Y.T. and Logan, W.F.W.E.: Myocardial contractility and the effects of beta-adrenergic blockade in hypothyroidism and hyperthyroidism. Clinical Science 34: 485–495 (1968).
  Google Scholar
• Hughes, G.: Management of thyrotoxic crisis with a beta adrenergic blocking agent (Pronethalol). British Journal of Clinical Practice 20: 579–581 (1966).
  PubMed CAS Google Scholar
• Ikram, H.: Haemodynamic effects of β-adrenergic blockade in hyperthyroid patients with and without heart failure. British Medical Journal 2: 1505–1507 (1977).
  Google Scholar
• Jones, D.K. and Solomon, S.: Thyrotoxic crisis masked by treatment with beta-blockers. British Medical Journal 283: 659 (1981).
  PubMed CAS Google Scholar
• Jones, G.R.; Lazarus, L.H. and Wynford-Thomas, D.: A study of long acting propranolol in the early management of hyperthyroidism. British Journal of Clinical Pharmacology 12: 825–828 (1981).
  PubMed CAS Google Scholar
• Jones, M.K.; John, R. and Jones, G.R.: The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyper-thyroid subjects. Clinical Endocrinology 13: 343–347 (1980).
  PubMed CAS Google Scholar
• Kapur, M.M.; Sarin, R.; Kumar, V.; Ananthakrishnan, N. and Joshi, K.D.: Evaluation of propranolol in the preoperative control of thyrotoxicosis. Indian Journal of Medical Research 67: 453–461 (1978).
  PubMed CAS Google Scholar
• Kaur, S.; Krassas, G. and Ramsay, I.: Sotalol in hyperthyroidism. Clinical Endocrinology 15: 627–634 (1981).
  PubMed CAS Google Scholar
• Karlberg, B.E.; Henriksson, K.G. and Andersson, R.G.G.: Cyclic adenosine 3′5′-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. Journal of Clinical Endocrinology and Metabolism 41: 282–289 (1974).
  Google Scholar
• Kristensen, B.O.; Steiness, E. and Weeke, J.: Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clinical Pharmacology and Therapeutics 23: 624–629 (1978).
  PubMed CAS Google Scholar
• Kvetny, J.; Frederikesen, P.K.; Jacobsen, J.G.; Haas, V.; Feldt-Rasmussen, U. and Date, J.: Propranolol in the treatment of thyrotoxicosis. A randomised double blind study. Acta Medica Scandinavica 209: 389–392 (1981).
  CAS Google Scholar
• Lamberg, B.A.: The medical thyroid crisis. Acta Medica Scandinavica 164: 479–496 (1959).
  PubMed CAS Google Scholar
• Landsberg, L.: Catecholamines and hyperthyroidism. Clinics in Endocrinology and Metabolism 6: 697–718 (1977).
  PubMed CAS Google Scholar
• Langer, A.; Hung, C.T.; McAnulty, J.A.; Harrigan, J.T. and Washington, E.: Adrenergic blockade: A new approach to hyperthyroidism during pregnancy. Obstetrics and Gynaecology 44: 181–186 (1974).
  CAS Google Scholar
• Leading Article: β-Adrenergic blockade and anxiety. Lancet 2: 611–612 (1976).
  Google Scholar
• Leading Article: β-Blockers in thyrotoxicosis. Lancet 1: 184–185 (1980).
  Google Scholar
• Lee, T.C.; Coffey, R.J.; Mackin, J.; Cobb, M.; Routon, J. and Canary, J.J.: The use of propranolol in the surgical treatment of thyrotoxic patients. Annals of Surgery 177: 643–647 (1973).
  PubMed CAS Google Scholar
• Levy, C.A.; Waite, J.H. and Dickey, R.: Thyrotoxicosis and pregnancy. Use of preoperative propranolol for thyroidectomy. American Journal of Surgery 133: 319–321 (1977).
  PubMed CAS Google Scholar
• Lewis, B.S.; Ehrenfeld, E.N.; Lewis, N. and Gotsman, M.S.: Echocardiographic LV function in thyrotoxicosis. American Heart Journal 97: 460–468 (1979).
  PubMed CAS Google Scholar
• Liaw, K.-Y.; Chang-Chien, Y.; Chang, C.-C and Chen, F.-W.: Propranolol in the surgical treatment of thyrotoxicosis. Journal of the Formosan Medical Association 76: 857–863 (1977).
  PubMed CAS Google Scholar
• Ljunggren, J.C. and Persson, B.: Pre-operative treatment of thyrotoxicosis with a beta-adrenergic blocking agent. Acta Chirurgica Scandinavica 141: 715–718 (1975).
  PubMed CAS Google Scholar
• Lotti, G.; Delitala, G.; Devilla, L.; Alagna, S. and Masala, A.: Reduction of plasma triiodothyronine (T3) induced by propranolol. Clinical Endocrinology 6: 405–410 (1977).
  PubMed CAS Google Scholar
• Lowe, D.C; Hadden, D.R.; Montgomery, D.A.D. and Weaver, J.A.: Propranolol as the sole treatment for thyrotoxicosis: Long term follow-up; in Robbins and Braverman (Eds) Thyroid Research, pp. 429–433 (Excerpta Medica, Amsterdam 1975).
  Google Scholar
• Lumholtz, I.B.; Busch-Sorensen, M.; Faber, J.; Friis, T.; Kirkegaard, C. and Siersbaek-Nielsen, K.: The influence of propranolol on the extrathyroidal metabolism of 3,3′,5′-triiodothyronine (reverse T3). Acta Medica Scandinavica 624 (Suppl.): 31–34 (1979).
  PubMed CAS Google Scholar
• Marsden, C.D.; Gimlette, T.H.D.; McAllister, R.G.; Own, D.A.L. and Miller, T.N.: Effect of β-adrenergic blockade on finger tremor and achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinologica 57: 353–362 (1968).
  PubMed CAS Google Scholar
• Mazzaferri, E.L.; Reynolds, J.C; Young, R.L.; Thomas, C.N. and Parisi, A.F.: Propranolol as primary therapy for thyrotoxicosis. Archives of Internal Medicine 136: 50–56 (1976).
  PubMed CAS Google Scholar
• McDevitt, D.G.: β-Adrenoceptor blockade in hyperthyroidism; in Shanks (Ed.) Advanced Medicine: Topics in Therapeutics, 3rd ed, pp. 100–115 (Pitman Medical, London 1977).
  Google Scholar
• McDevitt, D.G. and Nelson, J.K.: Comparative trial of atenolol and propranolol in hyperthyroidism. British Journal of Clinical Pharmacology 6: 233–237 (1978).
  PubMed CAS Google Scholar
• McDevitt, D.G.; Riddell, J.G.; Hadden, D.R. and Montgomery, D.A.D.: Catecholamine sensitivity in hyperthyroidism and hypothyroidism. British Journal of Clinical Pharmacology 6: 297–301 (1978).
  PubMed CAS Google Scholar
• McDevitt, D.G.; Shanks, R.G.; Hadden, D.R., Montgomery, D.A.D. and Weaver, J.A.: The role of the thyroid in the control of heart rate. Lancet 1: 998–1000 (1968).
  PubMed CAS Google Scholar
• McLarty, D.G.; Brownlie, B.E.W.; Alexander, W.D.; Papapetrou, P.D. and Horton, P.: Remission of thyrotoxicosis during treatment with propranolol. British Medical Journal 2: 332–335 (1973).
  PubMed CAS Google Scholar
• Michie, W.; Hamer-Hodges, D.W.; Pegg, C.A.S.; Orr, F.G.G. and Bewsher, P.D.: Beta-blockade and partial thyroidectomy for thyrotoxicosis. Lancet 1: 1009–1011 (1974).
  PubMed CAS Google Scholar
• Mortimer, C.H.; Anderson, D.C; Liendo-Ch, P.; Fisher, R.; Chan, V.; Self, M. and Besser, G.M.: Thyrotoxicosis: Relations between clinical state and biochemical changes during carbimazole treatment. British Medical Journal 1: 138–141 (1977).
  PubMed CAS Google Scholar
• Motulsky, H.J. and Insel, P.A.: Adrenergic receptors in man: Direct identification, physiologic regulation and clinical alterations. New England Journal of Medicine 307: 18–29 (1982).
  PubMed CAS Google Scholar
• Murchison, L.E.; Bewsher, P.D.; Chesters, M.I. and Ferrier, W.R.: Comparison of propranolol and practolol in the management of hyperthyroidism. British Journal of Clinical Pharmacology 3: 273–277 (1976).
  PubMed CAS Google Scholar
• Murchison, L.E.; How, J. and Bewsher, P.D.: Comparison of propranolol and metoprolol in the management of hyperthyroidism. British Journal of Clinical Pharmacology 8: 581–587 (1979).
  PubMed CAS Google Scholar
• Nelson, J.K. and McDevitt, D.G.: Comparative trial of propranolol and practolol in hyperthyroidism. British Journal of Clinical Pharmacology 2: 411–416 (1975).
  PubMed CAS Google Scholar
• Newman, J.J.; Virnig, N.L. and Athinarayanan, P.K.: Complications of propranolol use in neonatal thyrotoxicosis. American Journal of Diseases of Children 134: 707–708 (1980).
  PubMed CAS Google Scholar
• Nilsson, O.R.; Anderberg, B.; Karlberg, B.E. and Kagedal, B.: Cortisol, growth hormone and prolactin responses to insulin-induced hypoglycaemia in hyperthyroid patients before and during β-adrenoceptor blockade. Clinical Endocrinology 12: 581–588 (1980e).
  PubMed CAS Google Scholar
• Nilsson, O.R.; Andersson, R.G.G. and Karlberg, B.E.: Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3′,5′-monophosphate in hyperthyroid patients. Acta Endocrinologica 94: 38–45 (1980b).
  PubMed CAS Google Scholar
• Nilsson, O.R.; Kagedal, B. and Tegler, L.: Insulin release and carbohydrate tolerance in hyperthyroid patients during non-selective or selective β1-adrenoceptor blockade. Acta Endocrinologica 93: 179–185 (1980c).
  PubMed CAS Google Scholar
• Nilsson, O.R.; Karlberg, B.E.; Kagedal, B.; Tegler, L. and Almqvist, S.: Non-selective and selective β1-adrenoceptor blocking agents in the treatment of hyperthyroidism. Acta Medica Scandinavica 206: 21–25 (1979).
  PubMed CAS Google Scholar
• Nilsson, O.R.; Karlberg, B.E. and Soderberg, A.: Plasma catecholamines and cardiovascular responses to hypoglycaemia in hyperthyroidism before and during treatment with metoprolol or propranolol. Journal of Clinical Endocrinology and Metabolism 50: 906–911 (1980d).
  PubMed CAS Google Scholar
• Nilsson, O.R.; Melander, A. and Tegler, L.: Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients. European Journal of Clinical Pharmacology 18: 315–320 (1980a).
  PubMed CAS Google Scholar
• O’Malley, B.P.; Abbott, R.J.; Barnett, D.B.; Northover, B.J. and Rosenthal, F.D.: Propranolol versus carbimazole as the sole treatment for thyrotoxicosis. A consideration of circulating thyroid hormone levels and tissue thyroid function. Clinical Endocrinology 16: 545–552 (1982).
  PubMed Google Scholar
• Ortigosa, J.L.; Mendoza, F.; Argote, R.M.; Garcia, G.; Cervantes, C. and Parra, A.: Propranolol effect on plasma glucose, free fatty acid, insulin and growth hormone in Graves’ Disease. Metabolism 25: 1201–1207 (1976).
  PubMed CAS Google Scholar
• Papouchado, M.: Thyrotoxic periodic paralysis. Journal of the Royal Society of Medicine 73: 519–520 (1980).
  PubMed CAS Google Scholar
• Parker, J.L.W. and Lawson, D.H.: Death from thyrotoxicosis. Lancet 2: 894–895 (1973).
  PubMed CAS Google Scholar
• Parsons, V. and Jewitt, D.: Beta adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias. Postgraduate Medical Journal 43: 756–762 (1967).
  PubMed CAS Google Scholar
• Pearl, K.N. and Chambers, T.L.: Propranolol treatment of thyrotoxicosis in a premature infant. British Medical Journal 2: 738 (1977).
  PubMed CAS Google Scholar
• Peden, N.R.; Feely, J.; Browning, M.C.K.; Crooks, J.; Forrest, A.; Hamilton, W.F.; Isles, T. and Gunn, A.: The clinical and endocrine response to surgical treatment of thyrotoxicosis — effects of a short- and a long-acting β-blocker and potassium iodide. Scottish Medical Journal 28: 91–92 (1983).
  CAS Google Scholar
• Peden, N.R.; Gunn, A.; Browning, M.C.K.; Crooks, J.; Forrest, A.L.; Hamilton, W.F. and Isles, T.E.: Nadolol and potassium iodide in combination in the surgical treatment of thyrotoxicosis. British Journal of Surgery 69: 638–640 (1982a).
  PubMed CAS Google Scholar
• Peden, N.R.; Isles, T.E.; Stevenson, I.H. and Crooks, J.: Nadolol in thyrotoxicosis. British Journal of Clinical Pharmacology 13: 835–840 (1982b).
  PubMed CAS Google Scholar
• Pemberton, P.J.; McConnell, B. and Shanks, R.G.: Neonatal thyrotoxicosis treated with propranolol. Archives of Diseases of Children 49: 813–815 (1974).
  CAS Google Scholar
• Pimstone, B.L.: Beta-adrenergic blockade in thyrotoxicosis. South African Medical Journal 43 (Suppl. Dec): 27–29 (1969).
  Google Scholar
• Pimstone, B. and Joffe, B.: The use and abuse of beta-adrenergic blockade in the surgery of hyperthyroidism. South African Medical Journal 44: 1059–1061 (1970).
  PubMed CAS Google Scholar
• Pimstone, B.; Joffe, B.; Pimstone, N.; Bonnici, F. and Jackson, W.P.U.: Clinical response to long term propranolol therapy in hyperthyroidism. South African Medical Journal 43: 1203–1205 (1969).
  PubMed CAS Google Scholar
• Pimstone, N.; Marine, N. and Pimstone, B.: Beta-adrenergic blockade in thyrotoxic myopathy. Lancet 2: 490–493 (1968).
  Google Scholar
• Pruyn, S.C.; Phelan, J.P. and Buchanan, G.C.: Long-term propranolol therapy in pregnancy: Maternal and foetal outcome. American Journal of Obstetrics and Gynecology 135: 485–489 (1979).
  PubMed CAS Google Scholar
• Riddell, J.G.; Neill, J.D.; Kelly, J.G. and McDevitt, D.G.: Effects of thyroid dysfunction on propranolol kinetics. Clinical Pharmacology and Therapeutics 28: 565–574 (1980).
  PubMed CAS Google Scholar
• Ross, P.J.; Jones, M.K. and John, R.: The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects. Clinical Endocrinology 13: 27–31 (1980).
  PubMed CAS Google Scholar
• Rowlands, D.J.; Honnitt, G. and Markam, P.: Propranolol in disturbance of cardiac rhythm. British Medical Journal 1: 891–894 (1965).
  PubMed CAS Google Scholar
• Rubin, P.C.: Beta-blockers in pregnancy. New England Journal of Medicine 305: 1323–1327 (1981).
  PubMed CAS Google Scholar
• Rude, R.K.; Oldham, S.B.; Singer, F.R. and Nicoloff, J.T.: Treatment of thyrotoxic hypercalcaemia with propranolol. New England Journal of Medicine 294: 431–433 (1976).
  PubMed CAS Google Scholar
• Saunders, J.; Hall, S.E.; Crowther, A. and Sonksen, P.H.: The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis. Clinical Endocrinology 9: 62–72 (1978).
  Google Scholar
• Saunders, J.; Hall, S.E.H. and Sonksen, P.H.: Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism before and after treatment. Clinical Endocrinology 13: 33–44 (1980).
  PubMed CAS Google Scholar
• Schelling, J.L.; Scazziga, B.; Dufour, R.J.; Milinkovic, N. and Weber, A.A.: Effect of pindolol, a beta receptor antagonist in hyperthyroidism. Clinical Pharmacology and Therapeutics 14: 158–164 (1973).
  PubMed CAS Google Scholar
• Seino, Y.; Miyamoto, Y.; Mondera, K.; Taminato, T.; Matsukura, S. and Imura, H.: The role of the beta-adrenergic mechanism in the hypergastrinaemia of hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 50: 368–370 (1980).
  PubMed CAS Google Scholar
• Shanks, R.G.; Hadden, D.R.; Lowe, D.C.; McDevitt, D.G. and Montgomery, D.A.D.: Controlled trial of propranolol in thyrotoxicosis. Lancet 1: 993–994 (1969).
  PubMed CAS Google Scholar
• Shenfield, G.M.: Influence of thyroid dysfunction on drug pharmacokinetics. Clinical Pharmacokinetics 6: 275–297 (1981).
  PubMed CAS Google Scholar
• Solomon, D.H.: Pregnancy and PTU. New England Journal of Medicine 304: 538–539 (1981).
  PubMed CAS Google Scholar
• Solomon, D.H. and Kleeman, K.E.: Concepts of pathogenesis of Graves’ disease. Advances in Internal Medicine 22: 273–299 (1977).
  PubMed CAS Google Scholar
• Smith, C.S. and Howard, N.J.: Propranolol in treatment of neonatal thyrotoxicosis. Journal of Pediatrics 83: 1046–1048 (1973).
  PubMed CAS Google Scholar
• Sneddon, J.M. and Turner, P.: Adrenergic blockade and eye signs of thyrotoxicosis. Lancet 2: 525–527 (1966).
  PubMed CAS Google Scholar
• Starling, J.R. and Thomas, C.G.: Experience with the use of propranolol in the surgical management of thyrotoxicosis. World Journal of Surgery 1: 251–257 (1977).
  Google Scholar
• Stout, B.D.; Wiener, L. and Cox, W.J.: Combined alpha and beta sympathetic blockade in hyperthyroidism. Annals of Internal Medicine 70: 963–970 (1969).
  PubMed CAS Google Scholar
• Tanaka, T.; Yamaguchi, T.; Kuma, K. and Hidaka, H.: Effect of beta-adrenergic blockade on plasma dopamine-beta-hydroxylase activity and triiodothyronine in hyperthyroidism. Endocrinology (Japan) 27(4): 447–450 (1980).
  CAS Google Scholar
• Tawara, K.; Kawashima, K.; Ishikawa, H.; Yamamoto, K.; Saito, K.; Ebihara, A. and Yoshida, S.: Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients. European Journal of Clinical Pharmacology 19: 197–203 (1981).
  PubMed CAS Google Scholar
• Tevaarwerk, G.J. and Boyd, D.: Propranolol in thyrotoxicosis II. Serum thyroid hormone concentrations during subtotal thyroidectomy. Canadian Journal of Surgery 22(3): 264–266 (1979).
  CAS Google Scholar
• Toft, A.D.; Irvine, W.J. and Campbell, R.F.W.: Assessment by continuous cardiac monitoring of minimum duration of preoperative propranolol treatment in thyrotoxic patients. Clinical Endocrinology 5: 195–198 (1976).
  PubMed CAS Google Scholar
• Toft, A.D.; Irvine, W.J.; Sinclair, I.; McIntosh, D.; Seth, J. and Cameron, E.H.D.: Thyroid function after surgical treatment of thyrotoxicosis: A report of 100 cases treated with propranolol before operation. New England Journal of Medicine 298: 643–647 (1978).
  PubMed CAS Google Scholar
• Trench, A.J.; Buckley, F.P.; Drummond, G.B.; Arthur, G.R. and Scott, D.B.: Propranolol in thyrotoxicosis. Cardiovascular changes during thyroidectomy in patients pretreated with propranolol. Anaesthesia 33: 535–539 (1978).
  PubMed CAS Google Scholar
• Turner, P.: β-Adrenergic receptor blocking drugs in hyperthyroidism. Drugs 7: 48–54 (1974).
  PubMed CAS Google Scholar
• Turner, P.; Granville-Grossman, K.L. and Smart, J.V.: Effect of adrenergic receptor blockade on the tachycardia on thyrotoxicosis and anxiety state. Lancet 2: 1316–1318 (1965).
  PubMed CAS Google Scholar
• Utiger, R.D.: Treatment of Graves’ disease. New England Journal of Medicine 298: 681–682 (1978).
  PubMed CAS Google Scholar
• Uusitupa, M.; Aro, A.; Korhonen, T. and Jukka, E.: Beta-blockade, myopathy and thyrotoxicosis. British Medical Journal 280: 183 (1980).
  PubMed CAS Google Scholar
• Verhoeven, R.P., Visser, T.J.; Doctor, R.; Hennemann, G. and Schalekamp, M.A.D.H.: Plasma thyroxine, 3,3′,5′-triiodothyronine and 3,3′,5′-triiodothyronine during β-adrenergic blockade in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 44: 1002–1004 (1977).
  PubMed CAS Google Scholar
• Vinik, A.I.; Pimstone, B.L. and Hoffenberg, R.: Sympathetic nervous system blocking in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 28: 725–727 (1968).
  PubMed CAS Google Scholar
• Wahlberg, P. and Carlsson, S.-A.: Long-term control of thyrotoxicosis with the beta-blocker sotalol — a model of untreated hyperthyroidism? Acta Endocrinologica 87: 734–742 (1978).
  PubMed CAS Google Scholar
• Wahlberg, P.; Wennstrom, J. and Ekelund, P.: Control of thyrotoxicosis with sotalol. Annals of Clinical Research 8: 415–417 (1976).
  PubMed CAS Google Scholar
• Wells, P.G.; Feely, J.; Wilkinson, G.R. and Wood, A.J.J.: Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long term dosing. Clinical Pharmacology and Therapeutics 33: 603–608 (1983).
  PubMed CAS Google Scholar
• Wiener, L.; Stout, B.D. and Cox, J.W.: Influence of β-sympathetic blockade (propranolol) on the haemodynamics of hyperthyroidism. American Journal of Medicine 46: 227–233 (1969).
  PubMed CAS Google Scholar
• Wilkinson, R. and Burr, W.A.: The effect of nadolol on thyroid function; in Gross (Ed.) International Experience with Nadolol, a Long-acting β-Blocking Agent. International Congress and Symposium series/Royal Society of Medicine No. 37, pp. 51–56 (Academic Press and Royal Society of Medicine, London 1981).
  Google Scholar
• Wilson, W.R.; Theiler, E.O. and Fletcher, F.W.: Pharmacodynamic effects of beta-adrenergic receptor blockade in patients with hyperthyroidism. Journal of Clinical Investigation 43: 1697–1703 (1964).
  PubMed CAS Google Scholar
• Ycung, R.T. and Tse, T.F.: Thyrotoxic periodic paralysis — effect of propranolol. American Journal of Medicine 157: 584–590 (1974).
  Google Scholar
• Zonszein, J.; Santangelo, R.P.; Mackin, J.F.; Lee, T.C.; Coffey, R.J. and Canary, J.J.: Propranolol therapy in thyrotoxicosis. A review of 84 patients undergoing surgery. American Journal of Medicine 66: 411–416 (1979).
  PubMed CAS Google Scholar
• Zwillich, C.W.; Matthay, M.; Potts, D.E.; Alder, R.; Hofeldt, F. and Weil, J.H.: Thyrotoxicosis: Comparison of effects of thyroid ablation and beta-adrenergic blockade on metabolic rate and ventilatory control. Journal of Clinical Endocrinology and Metabolism 46: 491–500 (1978).
  PubMed CAS Google Scholar